|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
188,370,000 |
Market
Cap: |
16.70(B) |
Last
Volume: |
1,778,607 |
Avg
Vol: |
1,398,026 |
52
Week Range: |
$76.22 - $99 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 811 |
Guru Rank Value : 0.9 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
3,625 |
Total Buy Value |
$0 |
$0 |
$0 |
$314,469 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
1 |
Total Shares Sold |
139,229 |
182,993 |
316,353 |
594,697 |
Total Sell Value |
$12,316,080 |
$16,513,389 |
$28,948,007 |
$56,737,885 |
Total People Sold |
5 |
5 |
6 |
7 |
Total Sell Transactions |
11 |
15 |
24 |
53 |
End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Ajer Jeffrey Robert |
SVP, Chief Commercial Of |
|
2012-11-28 |
4 |
OE |
$14.39 |
$106,110 |
D/D |
5,916 |
16,486 |
|
- |
|
Wood Mark |
VP, Human Resources |
|
2012-11-23 |
4 |
AS |
$48.92 |
$130,367 |
D/D |
(2,665) |
32,364 |
|
- |
|
Wood Mark |
VP, Human Resources |
|
2012-11-23 |
4 |
OE |
$14.39 |
$54,394 |
D/D |
2,665 |
35,029 |
|
- |
|
Davis George Eric |
SVP, General Counsel |
|
2012-11-19 |
4 |
S |
$48.50 |
$357,106 |
D/D |
(7,363) |
51,322 |
|
- |
|
Davis George Eric |
SVP, General Counsel |
|
2012-11-19 |
4 |
OE |
$17.54 |
$129,147 |
D/D |
7,363 |
58,685 |
|
- |
|
Bienaime Jean Jacques |
Chief Executive Officer |
|
2012-11-16 |
4 |
S |
$48.05 |
$384,366 |
D/D |
(8,000) |
167,691 |
|
- |
|
Bienaime Jean Jacques |
Chief Executive Officer |
|
2012-11-16 |
4 |
OE |
$12.99 |
$103,920 |
D/D |
8,000 |
175,691 |
|
- |
|
Mueller Brian |
VP, Corporate Controller |
|
2012-11-15 |
4 |
AS |
$50.00 |
$790,600 |
D/D |
(15,812) |
15,340 |
|
- |
|
Mueller Brian |
VP, Corporate Controller |
|
2012-11-15 |
4 |
OE |
$14.39 |
$477,085 |
D/D |
15,812 |
31,152 |
|
- |
|
Baffi Robert |
EVP, Technical Operations |
|
2012-11-15 |
4 |
AS |
$51.00 |
$1,020,000 |
D/D |
(20,000) |
100,413 |
|
- |
|
Baffi Robert |
EVP, Technical Operations |
|
2012-11-15 |
4 |
OE |
$17.54 |
$350,800 |
D/D |
20,000 |
120,413 |
|
- |
|
Bienaime Jean Jacques |
Chief Executive Officer |
|
2012-11-14 |
4 |
S |
$48.50 |
$193,987 |
D/D |
(4,000) |
167,691 |
|
- |
|
Bienaime Jean Jacques |
Chief Executive Officer |
|
2012-11-14 |
4 |
OE |
$12.99 |
$51,960 |
D/D |
4,000 |
171,691 |
|
- |
|
Ajer Jeffrey Robert |
SVP, Chief Commercial Of |
|
2012-11-12 |
4 |
S |
$48.11 |
$12,750 |
D/D |
(265) |
10,570 |
|
- |
|
Davis George Eric |
SVP, General Counsel |
|
2012-11-12 |
4 |
S |
$48.63 |
$562,998 |
D/D |
(11,575) |
51,322 |
|
- |
|
Davis George Eric |
SVP, General Counsel |
|
2012-11-12 |
4 |
OE |
$17.54 |
$228,305 |
D/D |
11,466 |
62,897 |
|
- |
|
Heron Elaine J |
Director |
|
2012-11-12 |
4 |
S |
$48.32 |
$90,612 |
D/D |
(1,875) |
14,025 |
|
- |
|
Davis George Eric |
SVP, General Counsel |
|
2012-11-09 |
4 |
S |
$48.00 |
$4,237,296 |
D/D |
(87,500) |
51,322 |
|
- |
|
Davis George Eric |
SVP, General Counsel |
|
2012-11-09 |
4 |
OE |
$14.39 |
$1,503,316 |
D/D |
87,500 |
138,822 |
|
- |
|
Bienaime Jean Jacques |
Chief Executive Officer |
|
2012-11-09 |
4 |
S |
$48.42 |
$96,844 |
D/D |
(2,000) |
167,691 |
|
- |
|
Heron Elaine J |
Director |
|
2012-11-09 |
4 |
S |
$48.01 |
$1,440,351 |
D/D |
(30,000) |
15,900 |
|
- |
|
Bienaime Jean Jacques |
Chief Executive Officer |
|
2012-11-07 |
4 |
S |
$47.00 |
$236,470 |
D/D |
(5,000) |
169,691 |
|
- |
|
Lewis Alan |
Director |
|
2012-11-07 |
4 |
S |
$46.80 |
$702,000 |
D/D |
(15,000) |
15,900 |
|
- |
|
Lewis Alan |
Director |
|
2012-11-07 |
4 |
OE |
$17.33 |
$259,950 |
D/D |
15,000 |
30,900 |
|
- |
|
Heron Elaine J |
Director |
|
2012-11-07 |
4 |
S |
$46.44 |
$4,876,116 |
D/D |
(105,000) |
45,900 |
|
- |
|
1279 Records found
|
|
Page 15 of 52 |
|
|